FDA Approves Enzalutamide for Nonmetastatic Prostate Cancer FDA Approves Enzalutamide for Nonmetastatic Prostate Cancer
The oral therapy becomes the second androgen receptor-targeting therapy to be approved for use in this earlier disease setting.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news